Repros Therapeutics, Inc. (RPRX)

[io_io]

<<<<<"T becomes an unacceptable endpoint">>>>

Not to mention that it was unacceptable last year too.


Personally I think the FDA may have wanted to steer the drug where it is needed - I am most impressed by the AIHH paper that dewophile sourced - there is surely a large market and a REAL need there.

Plus that REAL need gives some protecting from perceived safety issues later on. This looks to me like a great investment and if I can get to a PC I will buy more on Monday.